Loading
Latest filing published 21 Oct 2026 for Stoke Therapeutics, Inc., €34.2M.
No signal scores available.
One trade, one date: on 21 October 2026, Edward Kaye disclosed a transaction of €34.2M in Stoke Therapeutics, Inc. No broader history exists yet. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration